Loading data
RCKTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Research and development expense | 142.02 m USD | 171.24 m USD | 186.34 m USD | 165.57 m USD | 125.48 m USD |
| Operating profit | -231.75 m USD | -273.21 m USD | -259.66 m USD | -224.34 m USD | -167.25 m USD |
| Interest expense | 1.89 m USD | 1.89 m USD | 1.88 m USD | 1.86 m USD | 2.98 m USD |
| Profit before tax | -223.12 m USD | -258.75 m USD | — | — | — |
| Income tax expense | 0 USD | 0 USD | — | — | — |
| Net income (reported basis) | -223.12 m USD | -258.75 m USD | -245.6 m USD | -221.86 m USD | -169.07 m USD |
| Net income attributable to common shareholders | -223.12 m USD | -258.75 m USD | -245.6 m USD | -221.86 m USD | -169.07 m USD |
| Basic earnings per share | -2.01 USD/share | -2.73 USD/share | -2.92 USD/share | -3.26 USD/share | -2.67 USD/share |
| Diluted earnings per share | -2.01 USD/share | -2.73 USD/share | -2.92 USD/share | -3.26 USD/share | -2.67 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.